M3 muscarinic receptors mediate acetylcholine-induced pulmonary vasodilation in pulmonary hypertension

BioScience Trends

Volumn 4, Issue 5, 2010, Pages 260-266

  Orii, Ryo ^a   Sugawara, Yasuhiko ^a   Sawamura, Shigehito ^a   Yamada, Yoshitsugu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Muscarinic receptors; Pulmonary vasodilation; Rabbit

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 DIPHENYLACETOXY 1,1 DIMETHYLPIPERIDINIUM; 4-DIPHENYLACETOXY-1,1-DIMETHYLPIPERIDINIUM; ACETYLCHOLINE; DIAMINE; METHOCTRAMINE; MUSCARINIC M3 RECEPTOR; PIPERIDINE DERIVATIVE; PIRENZEPINE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; LUNG; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY HYPERTENSION; RABBIT; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINE; ANIMALS; DIAMINES; HYPERTENSION, PULMONARY; LUNG; PIPERIDINES; PIRENZEPINE; RABBITS; RECEPTOR, MUSCARINIC M3; VASODILATION;

EID: 79952289232     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288:373-376.
2. Catravas JD, Buccafusco JJ, El Kashef H. Effects of acetylcholine in the pulmonary circulation of rabbits. J Pharmacol Exp Ther. 1984; 231:236-241.
3. Altiere RJ, Kiritsy-Roy JA, Catravas JD. Acetylcholineinduced contractions in isolated rabbit pulmonary arteries: Role of thromboxane A2. J Pharmacol Exp Ther. 1986; 236:535-541.
4. El-Kashef H, Catravas JD. The nature of muscarinic receptor subtypes mediating pulmonary vasoconstriction in the rabbit. Pulm Pharmacol. 1991; 4:8-19.
5. Barman SA, Senteno E, Smith S , Taylor AE. Acetylcholines effect on vascular resistance and compliance in the pulmonary circulation. J Appl Physiol. 1989; 67:1495-1503.
6. Hyman AL, Kadowitz PJ. Influence of tone on responses to acetylcholine in the rabbit pulmonary vascular bed. J Appl Physiol. 1989; 67:1388-1394.
7. Hyman AL, Kadowitz PJ. Tone-dependent responses to acetylcholine in the feline pulmonary vascular bed. J Appl Physiol. 1988; 64:2002-2009.
8. Du HL, Yamada Y, Orii R, Suwa K, Hanaoka K. Vagal and sympathetic denervation in the development of oleic acid-induced pulmonary edema. Respir Physiol. 1997; 107:251-261.
9. Du H, Orii R, Yamada Y, Hayashida M, Kin N, Suwa K, Hanaoka K. Pancuronium increases pulmonary arterial pressure in lung injury. Br J Anaesth. 1996; 77:526-529.
10. Eglen RM, Choppin A, Watson N. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci. 2001; 22:409-414.
11. Altiere RJ, Travis DC, Roberts J, Thompson DC. Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries. J Pharmacol Exp Ther. 1994; 270:269-276.
12. Hakim TS, Michel RP, Chang HK. Partitioning of pulmonary vascular resistance in dogs by arterial and venous occlusion. J Appl Physiol. 1982; 52:710-715.
13. Townsley MI, Korthuis RJ, Rippe B, Parker JC, Taylor AE. Validation of double vascular occlusion method for Pc,i in lung and skeletal muscle. J Appl Physiol. 1986; 61:127-132.
14. Rippe B, Parker JC, Townsley MI, Mortillaro NA, Taylor AE. Segmental vascular resistances and compliances in dog lung. J Appl Physiol. 1987; 62:1206-1215.
15. Cope DK, Grimbert F, Downey JM, Taylor AE. Pulmonary capillary pressure: A review. Crit Care Med. 1992; 20:1043-1056.
16. Cherry PD, Gillis CN. Evidence for the role of endothelium-derived relaxing factor in acetylcholineinduced vasodilatation in the intact lung. J Pharmacol Exp Ther. 1987; 241:516-520.
17. McCormack DG, Mak JC, Minette P, Barnes PJ. Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery. Eur J Pharmacol. 1988; 158:293-297.
18. Wakerlin GE Jr, Benson GV, Pearl RG. A thromboxane analog increases pulmonary capillary pressure but not permeability in the perfused rabbit lung. Anesthesiology. 1991; 75:475-480.
19. Bonner TI, Buckley NJ, Young AC, Brann MR. Identification of a family of muscarinic acetylcholine receptor genes. Science. 1987; 237:527-532.
20. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther. 1991; 256:727-733.
21. Bonner TI, Young AC, Brann MR, Buckley NJ. Cloning and expression of the human and rat M5 muscarinic acetylcholine receptor genes. Neuron. 1988; 1:403-410.
22. Peretto I, Petrillo P, Imbimbo BP. Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists. Med Res Rev. 2009; 29:867-902.
23. Kenakin TP. The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev. 1984; 36:165-222.
24. Mitchelson F. Muscarinic receptor differentiation. Pharmacol Ther. 1988; 37:357-423.
25. Caulfield MP. Muscarinic receptors - characterization, coupling and function. Pharmacol Ther. 1993;
26. Hammer R, Berrie CP, Birdsall NJ, Burgen AS, Hulme EC. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980; 283:90-92.
27. Orphanos SE, Catravas JD. Muscarinic receptor subtype (M1) identification on rabbit pulmonary vascular endothelium in vivo. Pharmacology. 1989; 39:253-264.
28. El Kashef HA, Catravas JD. Prostanoid mediation of pulmonary vascular response to acetylcholine in rabbits. Am J Physiol. 1986; 251 (4 Pt 2):H808-H814.
29. Wilson PS, Khimenko PL, Barnard JW, Moore TM, Taylor AE. Muscarinic agonists and antagonists cause vasodilation in isolated rat lung. J Appl Physiol. 1995; 78:1404-1411.
30. Okanlami OA, Fryer AD, Hirshman C. Interaction of nondepolarizing muscle relaxants with M2 and M3 muscarinic receptors in guinea pig lung and heart. Anesthesiology. 1996; 84:155-161.
31. Hou VY, Hirshman CA, Emala CW. Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors. Anesthesiology. 1998; 88:744-750.